Literature DB >> 1953015

Outcome in tyrosinaemia type II.

D G Barr1, J M Kirk, S C Laing.   

Abstract

Tyrosinaemia type II was diagnosed in a boy with failure to thrive and in his sister on neonatal screening. On diet the outcome, at 12 and 10 years respectively, has been excellent in respect of oculocutaneous sequelae, growth, and psychomotor development, contrasting with the generally unfavourable outcome in most reported cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953015      PMCID: PMC1793529          DOI: 10.1136/adc.66.10.1249

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  1 in total

1.  Isolation and characterization of the human tyrosine aminotransferase gene.

Authors:  R Rettenmeier; E Natt; H Zentgraf; G Scherer
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

  1 in total
  3 in total

1.  Dietetic therapy of Richner-Hanhart syndrome.

Authors:  T I Farag
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 5.344

Review 2.  Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.

Authors:  Jean-Baptiste Arnoux; Kim-Hanh Le Quan Sang; Anais Brassier; Coraline Grisel; Aude Servais; Julien Wippf; Sandrine Dubois; Nicolas Sireau; Chantal Job-Deslandre; Lakshminarayan Ranganath; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2015-04-10       Impact factor: 4.982

3.  Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II)

Authors:  D G Paige; P Clayton; A Bowron; J I Harper
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.